Lexicon's president to step down as decision date looms; Sarepta welcomes Lilly, GSK vet to board
→ The top leadership at Lexicon Pharmaceuticals is still undergoing a major makeover as president and COO Jeff Wade heads for …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.